https://www.aigom.it/wp-content/uploads/2023/12/WE-BRCA-BREASY.jpg7931052Alessia Losihttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngAlessia Losi2023-12-04 10:32:202023-12-04 10:34:16WE BRCA BREAST | AIGOM ha dato il patrocinio a questo importante incontro scientifico
https://www.aigom.it/wp-content/uploads/2023/12/MAINTAIN-TRIAL.jpg821581Alessia Losihttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngAlessia Losi2023-12-04 10:20:012023-12-04 10:21:34Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial.
